Allison Berg
About Allison Berg
Allison Berg serves as the Senior Director of Biology Neurosciences at Aitia, bringing extensive experience from her previous roles at Pfizer and Foldrx Pharmaceuticals. She holds a PhD in Pharmacology from the University of Virginia and has a strong background in drug development, particularly in the areas of rare diseases and neuroscience.
Current Role at Aitia
Allison Berg serves as the Senior Director of Biology Neurosciences at Aitia, a position she has held since 2024. Based in Cambridge, Massachusetts, she focuses on advancing the understanding of biological systems related to neuroscience. Her role involves leading projects and collaborating with external academic institutions and contract research organizations (CROs).
Previous Experience at Pfizer
Allison Berg has extensive experience at Pfizer, where she held multiple roles over several years. She worked as an Associate Research Fellow from 2022 to 2023, a Senior Principal Scientist from 2018 to 2022, a Principal Scientist from 2013 to 2018, and a Senior Scientist from 2010 to 2013. Her work at Pfizer included leading preclinical drug programs and authoring critical documents for candidate-level assets.
Education and Expertise
Allison Berg's educational background includes a Bachelor of Arts in Biology from the University of Virginia, a Master of Science in Genetics from Tufts University School of Medicine, and a PhD in Pharmacology from the University of Virginia. Her academic training provides a strong foundation for her expertise in drug development, particularly in the areas of rare diseases and neuroscience.
Background in Pharmaceuticals
Before her tenure at Aitia, Allison Berg worked at Foldrx Pharmaceuticals as a Scientist from 2009 to 2010. Her background in pharmaceuticals includes significant contributions to drug programs focused on small molecules and genetic medicines. She has a strong understanding of ion channels and their implications in neurological and neurodegenerative diseases.
Research Contributions
Allison Berg has authored nonclinical summaries and out-licensing documents for candidate-level assets. She serves as a project lead and subject matter expert, contributing strategically to portfolios that involve rare diseases, neuroscience, and respiratory physiology. Her technical expertise includes slice patch electrophysiology and heterologous systems for screening.